Jianhao Zeng

机构：Shunde Polytechnic, Translational Therapeutics (United States), Alibaba Group (China), University of Virginia, University of Pennsylvania · ORCID：0000-0002-1026-729X

发表论文 58 篇 · 总被引 262 次 · h-index 8

代表论文

• CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery (2025 · Molecular Therapy · 被引 41)
• CAT-DM: Controllable Accelerated Virtual Try-On with Diffusion Model (2024 · 被引 38)
• Assembled Embedded 3D Hydrogel System for Asynchronous Drug Delivery to Inhibit Postoperative Recurrence of Malignant Glioma and Promote Neurological Recovery (2024 · Advanced Functional Materials · 被引 8)
• Rapid receptor internalization potentiates CD7-targeted lipid nanoparticles for efficient mRNA delivery to T cells and in vivo CAR T-cell engineering (2026 · Journal of Controlled Release · 被引 4)
• Robust-MVTON: Learning Cross-Pose Feature Alignment and Fusion for Robust Multi-View Virtual Try-On (2025 · 被引 2)
• A novel optimized orthotopic mouse model for brain metastasis with sustained cerebral blood circulation and capability of multiple delivery (2025 · Clinical & Experimental Metastasis · 被引 2)